scholarly article | Q13442814 |
P356 | DOI | 10.1002/NBM.1426 |
P698 | PubMed publication ID | 19650073 |
P50 | author | Tone F. Bathen | Q61104171 |
Ingrid Susann Gribbestad | Q65706743 | ||
Steinar Lundgren | Q65706815 | ||
Anna M Bofin | Q88506963 | ||
Pål Erik Goa | Q92895190 | ||
Else M Huuse | Q114422035 | ||
P2093 | author name string | Line R Jensen | |
Tina B Pedersen | |||
P2860 | cites work | Telling cells how to die: docetaxel therapy in cancer cell lines. | Q36766382 |
P433 | issue | 1 | |
P921 | main subject | docetaxel | Q420436 |
P304 | page(s) | 56-65 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | NMR in Biomedicine | Q3061252 |
P1476 | title | Assessment of early docetaxel response in an experimental model of human breast cancer using DCE-MRI, ex vivo HR MAS, and in vivo 1H MRS. | |
P478 | volume | 23 |
Q48196734 | Anti-angiogenic therapy affects the relationship between tumor vascular structure and function: A correlation study between micro-computed tomography angiography and dynamic contrast enhanced MRI. |
Q38712030 | Applications of high-resolution magic angle spinning MRS in biomedical studies I-cell line and animal models |
Q38989194 | Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results |
Q36134678 | DCE-MRI-Derived Parameters in Evaluating Abraxane-Induced Early Vascular Response and the Effectiveness of Its Synergistic Interaction with Cisplatin |
Q30687678 | DCE@urLAB: a dynamic contrast-enhanced MRI pharmacokinetic analysis tool for preclinical data. |
Q39995682 | DCEMRI.jl: a fast, validated, open source toolkit for dynamic contrast enhanced MRI analysis |
Q40309071 | Effects of a high-caloric diet and physical exercise on brain metabolite levels: a combined proton MRS and histologic study |
Q34101555 | In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts |
Q35497704 | Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy |
Q92282846 | Induction of G2/M Phase Arrest by Diosgenin via Activation of Chk1 Kinase and Cdc25C Regulatory Pathways to Promote Apoptosis in Human Breast Cancer Cells |
Q37689772 | Interplay of choline metabolites and genes in patient-derived breast cancer xenografts |
Q39116695 | Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts |
Q30881669 | MRI reveals the in vivo cellular and vascular response to BEZ235 in ovarian cancer xenografts with different PI3-kinase pathway activity. |
Q34496670 | Molecular imaging in cancer treatment |
Q34041364 | Monitoring the Effect of Docetaxel Treatment in MCF7 Xenografts Using Multimodal In Vivo and Ex Vivo Magnetic Resonance Methods, Histopathology, and Gene Expression |
Q57181925 | Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models |
Q35334958 | Quantitative effects of using compressed sensing in dynamic contrast enhanced MRI |
Q35786155 | Robustness of quantitative compressive sensing MRI: the effect of random undersampling patterns on derived parameters for DCE- and DSC-MRI |
Q38939387 | [18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells |